Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers

NCT05430958 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was withdrawn due to sponsor decision.

Conditions

Coronavirus Infection

Interventions

DRUG: INO-4800
DRUG: INO-9112
DEVICE: CELLECTRA® 2000

Sponsor

Inovio Pharmaceuticals